Marcus Horwitz, MD

Melioidosis vaccine shows promise in mouse study

A vaccine against the bacterium, Burkholderia pseudomallei, that causes melioidosis was tested in a mouse study and found to be highly protective against the disease, according to UCLA researchers.

What is Burkholderia pseudomallei? What is melioidosis? And what about this vaccine study?

Joining me today to answer these questions and more is Marcus Horwitz, MD. Dr Horwitz is a Distinguished Professor of Medicine, in the division of infectious diseases, and of Microbiology, Immunology and Molecular Genetics at the David Geffen School of Medicine at UCLA. He is also the senior author of the paper on this vaccine in the journal mBio.

CDC Yellow Book 2024: Health Information for International Travel